MLPT Insider Trading Activity and SEC Form 4 Filings
MLPT insider trading summary
Over the past 12 months, insiders at MapLight Therapeutics, Inc. (MLPT) reported 5 open-market purchases worth $65.4M by 1 insider and no sales on SEC Form 4. Net insider buying was $65.4M.
Latest MLPT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 14, 2026 | Catalyst4, Inc. | Insider | Buy | $50.1M (4,400,000 @ $11.38) |
| Jul 30, 2026 | Catalyst4, Inc. | Insider | Buy | $13.0M (1,000,000 @ $13.00) |
| Jul 29, 2026 | Catalyst4, Inc. | Insider | Buy | $38K (3,000 @ $12.63) |
| Jul 28, 2026 | Catalyst4, Inc. | Insider | Buy | $1.5M (141,088 @ $10.74) |
| Jul 28, 2026 | Catalyst4, Inc. | Insider | Buy | $761K (65,137 @ $11.69) |
| Oct 28, 2025 | Catalyst4, Inc. | Insider | Buy | $92.5M (5,441,176 @ $17.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.